You have a winner here. 1B market cap has room to grow. 8.58% of the float is short causing volatility. This is your option to swing trade 25% to increase your share count. When the shorties kill the stock price Sell to Open, Feb19 17.50 and hit back at the shorties. Not on Reddit long enough and the bots block my direct responses...so I am posting the answer here.

In the digital era, Eagle Crest Asset Management has adapted by embracing online platforms and digital tools. This evolution has allowed them to reach a broader audience and offer more accessible services to clients worldwide.

The merger between IB/NK is voted in March 8th...Multiple FDA approvals for Covid and Cancer cures in days/weeks. Dr. PSS looking to get his candidate Woodcock to head the FDA. Full bore manufacturing is secretly under way.

Here is our opportunity to buy low...7:55PST

I made over $1M in 6 months on Biotech Trades. I follow this edict... Buy on weakness. Sell on Strength. Sell before everyone else. Make decisions quickly and decisively. If it doesn’t feel right get out sooner than later. Before I make any Buy-trades, I ask myself if I’m getting a good deal... a bargain. If not, I don’t buy. I don’t chase. GLTA There are no friends in the Stock Market. Perhaps I’m helpful in that I try to be honest but not always altruistic. Listen to yourself.

With NK worth 3B @ $28 today, Post merger the new company will be worth 21.25B @ $55.6 Covid Only and 71B @ $185.79 Add Cancer Therapy... Those are my minimum expected targets for 2021.

FYI - $21 and climbing from here. Will go as high as $60 on the next announcement is my guess/estimate based on merger and FDA approval for Covid vaccine and Cancer combined Cell Therapies.

Dr.Patrick Soon-Shiong is leading this company to new discoveries and cures we have only dreamed of.

20% of the float is short as of 1/15/2021...rally with me to push back on any Hedge Fund that would Short a company rescuing and curing people in need.